|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blum MA, Takashi T, Suzuki A and Ajani JA:
Management of localized gastric cancer. J Surg Oncol. 107:265–270.
2013. View Article : Google Scholar
|
|
3
|
Okamoto T, Tsuburaya A, Kameda Y, et al:
Prognostic value of extracapsular invasion and fibrotic focus in
single lymph node metastasis of gastric cancer. Gastric Cancer.
11:160–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zagouri F, Papadimitriou CA, Dimopoulos MA
and Pectasides D: Molecularly targeted therapies in
unresectable-metastatic gastric cancer: a systematic review. Cancer
Treat Rev. 37:599–610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jang BG and Kim WH: Molecular pathology of
gastric carcinoma. Pathobiology. 78:302–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu G and Wang Y: Functional diversity of
mammalian type 2C protein phosphatase isoforms: new tales from an
old family. Clin Exp Pharmacol Physiol. 35:107–112. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bulavin DV, Phillips C, Nannenga B,
Timofeev O, Donehower LA, Anderson CW, Appella E and Fornace AJ Jr:
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis
through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf)
pathway. Nat Genet. 36:343–350. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Yang Y, Peng Y, Austin RJ, van
Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey
T, Lowe SW and Powers S: Oncogenic properties of PPM1D located
within a breast cancer amplification epicenter at 17q23. Nat Genet.
31:133–134. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirasawa A, Saito-Ohara F, Inoue J, Aoki
D, Susumu N, Yokoyama T, Nozawa S, Inazawa J and Imoto I:
Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas
with poor prognosis and identification of PPM1D and APPBP2 as
likely amplification targets. Clin Cancer Res. 9:1995–2004.
2003.PubMed/NCBI
|
|
10
|
Saito-Ohara F, Imoto I, Inoue J, Hosoi H,
Nakagawara A, Sugimoto T and Inazawa J: PPM1D is a potential target
for 17q gain in neuroblastoma. Cancer Res. 63:1876–1883.
2003.PubMed/NCBI
|
|
11
|
Demidov ON, Kek C, Shreeram S, Timofeev O,
Fornace AJ, Appella E and Bulavin DV: The role of the MKK6/p38 MAPK
pathway in Wip1-dependent regulation of ErbB2-driven mammary gland
tumorigenesis. Oncogene. 26:2502–2506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loukopoulos P, Shibata T, Katoh H, Kokubu
A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I,
Ohki M, Inazawa J and Hirohashi S: Genome-wide array-based
comparative genomic hybridization analysis of pancreatic
adenocarcinoma: identification of genetic indicators that predict
patient outcome. Cancer Sci. 98:392–400. 2007. View Article : Google Scholar
|
|
13
|
Wang P, Rao J, Yang H, Zhao H and Yang L:
Wip1 over-expression correlated with TP53/p14(ARF) pathway
disruption in human astrocytomas. J Surg Oncol. 104:679–684. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu E, Ahn YS, Jang SJ, Kim MJ, Yoon HS,
Gong G and Choi J: Overexpression of the wip1 gene abrogates the
p38 MAPK/p53/Wip1 pathway and silences p16 expression in human
breast cancers. Breast Cancer Res Treat. 101:269–278. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Satoh N, Maniwa Y, Bermudez VP, Nishimura
K, Nishio W, Yoshimura M, Okita Y, Ohbayashi C, Hurwitz J and
Hayashi Y: Oncogenic phosphatase Wip1 is a novel prognostic marker
for lung adenocarcinoma patient survival. Cancer Sci.
102:1101–1106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu W, Feng Z, Modica I, Klimstra DS, Song
L, Allen PJ, Brennan MF, Levine AJ and Tang LH: Gene amplifications
in well-differentiated pancreatic neuroendocrine tumors inactivate
the p53 pathway. Genes Cancer. 1:360–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Castellino RC, De Bortoli M, Lu X, Moon
SH, Nguyen TA, Shepard MA, Rao PH, Donehower LA and Kim JY:
Medulloblastomas overexpress the p53-inactivating oncogene
WIP1/PPM1D. J Neurooncol. 86:245–256. 2008. View Article : Google Scholar : PubMed/NCBI
|
